Clinical Trials Directory

Trials / Unknown

UnknownNCT05841901

Huang-long Zhi-xiao Granule Improves the Control Rate of Chronic Persistent of Asthma

Evaluation of the Efficacy and Mechanism of Action of Huang-long Zhi-xiao Granule to Improve the Control Rate of Chronic Persistent of Asthma

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
224 (estimated)
Sponsor
Henan University of Traditional Chinese Medicine · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The goal of this observational study is to test the Evaluation of the efficacy and mechanism of action about Huang-long Zhi-xiao Granule to improve the control rate of Asthma chronic duration. The main questions it aims to answer are: * \[Relying on the top-level experimental design, scientifically evaluated the efficacy and safety of Huang-long Zhi-xiao Granule in patients with chronic asthma (hot asthma), and provided evidence support for the clinical application of Classical Prescriptions.\] * \[Through the retained sample to test Asthma-related inflammatory indicators, immunoglobulins, T cell subsets, etc. To investigate the mechanism of action of Huang-long Zhi-xiao Granule in patients with chronic duration of asthma (hot asthma).\]

Detailed description

Bronchial asthma attacks are erratic and difficult to heal, which seriously affects the quality of life of patients, and their physical and mental health is also seriously affected by asthma. This study will conduct clinical observations in patients with chronic persistence (hot wheezing) of bronchial asthma, scientifically evaluate the efficacy and safety of Huanglong Anti-Wheezing in patients with asthma chronic duration (hot wheezing), and provide evidence support for the clinical application of Huanglong Anti-Wheezing Formula.

Conditions

Interventions

TypeNameDescription
DRUGHuang-long Zhi-xiao GranuleThe experimental group was given Huang-long Zhi-xiao Granule.1 dose per day, oral in 2 divided doses, 1 course every 4 weeks, for a total of 8 weeks of treatment.
DRUGHuang-long Zhi-xiao Granule placeboThe toncral group was given placebo Huang-long Zhi-xiao Granule.The course of treatment was the same as that of the experimental group.

Timeline

Start date
2023-06-01
Primary completion
2024-02-01
Completion
2024-12-01
First posted
2023-05-03
Last updated
2023-05-03

Source: ClinicalTrials.gov record NCT05841901. Inclusion in this directory is not an endorsement.

Huang-long Zhi-xiao Granule Improves the Control Rate of Chronic Persistent of Asthma (NCT05841901) · Clinical Trials Directory